These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1695489)

  • 1. Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts.
    Gomez G; Townsend CM; Green DW; Rajaraman S; Greeley GH; Thompson JC
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G86-92. PubMed ID: 1695489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of pancreatic growth and gallbladder contractility by bile salts.
    Gomez G; Townsend CM; Maani R; Singh P; Greeley GG; Thompson JC
    Am J Surg; 1989 Jan; 157(1):20-6. PubMed ID: 2910123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective action of luminal bile salts in necrotizing acute pancreatitis in mice.
    Gomez G; Townsend CM; Green DW; Rajaraman S; Uchida T; Greeley GH; Soloway RD; Thompson JC
    J Clin Invest; 1990 Jul; 86(1):323-31. PubMed ID: 1694866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous cholecystokinin regulates growth of human cholangiocarcinoma.
    Evers BM; Gomez G; Townsend CM; Rajaraman S; Thompson JC
    Ann Surg; 1989 Sep; 210(3):317-22; discussion 322-3. PubMed ID: 2476084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic effect of oral cholestyramine, a bile salt sequestrant, and exogenous cholecystokinin on insulin release in rats.
    Kogire M; Gomez G; Uchida T; Ishizuka J; Greeley GH; Thompson JC
    Pancreas; 1992; 7(1):15-20. PubMed ID: 1557341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor.
    Rosewicz S; Lewis LD; Wang XY; Liddle RA; Logsdon CD
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G733-8. PubMed ID: 2468294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK; Permert J; Kazakoff KR; Pour PM; Zuker KA; Bilchik AJ; Adrian TE
    Carcinogenesis; 1993 May; 14(5):1021-6. PubMed ID: 7684953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
    Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
    Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
    Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
    Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
    Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CCK in the regulation of secretion and adaptation in the pig pancreas.
    Lhoste EF; Gueugneau AM; Garofano A; Philippe C; Levenez F; Corring T
    Pancreas; 1995 Jul; 11(1):86-94. PubMed ID: 7667247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.